Patents by Inventor Bernard FIORETTI

Bernard FIORETTI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mixture of resveratrol supported on metal hydroxide and non-supported pure resveratrol for treating female fertility
    Patent number: 12171728
    Abstract: A formulation of a dietary supplement for the improvement of female fertility in the human species based on the use of a definite stoichiometry of resveratrol with different pharmacokinetic profiles is described. The mixture is used alone or in combination with nutrients with antioxidant properties and not, used in female subfertility such as N-acetil-cysteine; Melatonin Vitamins A, C, D, E, B2, B3, B6, B12, folic acid, inositol, zinc, selenium, Coenzyme QIO, A-lipoic acid, arginine and Lycium barbarum berry extracts.
    Type: Grant
    Filed: April 16, 2019
    Date of Patent: December 24, 2024
    Assignee: S&R FARMACEUTICI S.P.A.
    Inventors: Bernard Fioretti, Lucio Leonardi
  • NUTRACEUTICAL OR PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF POLYCYSTIC OVARY SYNDROME OR OF DISEASES OR DISORDERS RELATED THERETO
    Publication number: 20220395460
    Abstract: A pharmaceutical or nutraceutical composition having at least one inositol and resveratrol for use in a) preventive and/or curative treatment in metabolic disorders related to polycystic ovary syndrome; b) treatment to reduce symptoms associated with polycystic ovary syndrome such as menstrual cycle alterations and infertility; and/or c) to decrease glucose, triglyceride and BMI levels in subjects with metabolic syndrome.
    Type: Application
    Filed: January 24, 2022
    Publication date: December 15, 2022
    Inventors: Bernard FIORETTI, Lucio LEONARDI
  • Nutraceutical or pharmaceutical composition for use in the treatment of polycystic ovary syndrome or of diseases or disorders related thereto
    Patent number: 11246834
    Abstract: A pharmaceutical or nutraceutical composition having at least one inositol and resveratrol for use in a) preventive and/or curative treatment in metabolic disorders related to polycystic ovary syndrome; b) treatment to reduce symptoms associated with polycystic ovary syndrome such as menstrual cycle alterations and infertility; and/or c) to decrease glucose, triglyceride and BMI levels in subjects with metabolic syndrome.
    Type: Grant
    Filed: April 13, 2017
    Date of Patent: February 15, 2022
    Assignee: S&R FARMACEUTICI S.P.A.
    Inventors: Bernard Fioretti, Lucio Leonardi
  • USE OF A BERBERIS AND RESVERATROL MIXTURE TO CONTROL DYSLIPIDEMIA
    Publication number: 20220023274
    Abstract: A pharmaceutical or nutraceutical composition or a food supplement including a mixture of berberine and resveratrol for use in treatment and/or control of dyslipidemia is described, wherein resveratrol is co-precipitated or supported on a salt or hydroxide of a divalent or trivalent metal.
    Type: Application
    Filed: December 16, 2019
    Publication date: January 27, 2022
    Inventors: Bernard FIORETTI, Lucio LEONARDI
  • MIXTURE OF RESVERATROL SUPPORTED ON METAL HYDROXIDE AND NON-SUPPORTED PURE RESVERATROL FOR TREATING FEMALE FERTILITY
    Publication number: 20210169825
    Abstract: A formulation of a dietary supplement for the improvement of female fertility in the human species based on the use of a definite stoichiometry of resveratrol with different pharmacokinetic profiles is described. The mixture is used alone or in combination with nutrients with antioxidant properties and not, used in female subfertility such as N-acetil-cysteine; Melatonin Vitamins A, C, D, E, B2, B3, B6, B12, folic acid, inositol, zinc, selenium, Coenzyme Q10, A-lipoic acid, arginine and Lycium barbarum berry extracts.
    Type: Application
    Filed: April 16, 2019
    Publication date: June 10, 2021
    Inventors: Bernard FIORETTI, Lucio LEONARDI
  • NUTRACEUTICAL OR PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF POLYCYSTIC OVARY SYNDROME OR OF DISEASES OR DISORDERS RELATED THERETO
    Publication number: 20190125675
    Abstract: A pharmaceutical or nutraceutical composition having at least one inositol and resveratrol for use in a) preventive and/or curative treatment in metabolic disorders related to polycystic ovary syndrome; b) treatment to reduce symptoms associated with polycystic ovary syndrome such as menstrual cycle alterations and infertility; and/or c) to decrease glucose, triglyceride and BMI levels in subjects with metabolic syndrome.
    Type: Application
    Filed: April 13, 2017
    Publication date: May 2, 2019
    Inventors: Bernard FIORETTI, Lucio LEONARDI